| 1 |
35081606 | Effects of CYP2C19, CYP2C9 and CYP3A4 gene polymorphisms on plasma voriconazole levels in Chinese pediatric patients. | 2022 Jun 1 |
4 |
| 2 |
33814360 | A review of pharmacokinetic drug interactions between antimicrobial and antiseizure medications in children. | 2021 Apr 1 |
1 |
| 3 |
32094096 | The role of candidate genetic polymorphisms in the interaction between voriconazole and cyclosporine in patients undergoing allogeneic hematopoietic cell transplantation: An explorative study. | 2020 Apr |
1 |
| 4 |
29945531 | Significant drug interaction between voriconazole and dexamethasone: A case report. | 2019 Jul |
1 |
| 5 |
29578577 | Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects. | 2018 Jul |
2 |
| 6 |
27853934 | Evaluation of In Vitro Cytochrome P450 Inhibition and In Vitro Fate of Structurally Diverse N-Oxide Metabolites: Case Studies with Clozapine, Levofloxacin, Roflumilast, Voriconazole and Zopiclone. | 2017 Aug |
1 |
| 7 |
27937048 | Effects of cytochrome P450 3A4 and non-genetic factors on initial voriconazole serum trough concentrations in hematological patients with different cytochrome P450 2C19 genotypes. | 2017 Dec |
1 |
| 8 |
27191765 | Dose regimens for Chinese adult liver transplant recipients according to the genetic polymorphisms of CYP2C9, CYP2C19, and CYP3A5 in recipients and donors. | 2016 Aug |
1 |
| 9 |
27306545 | The Impact of Model-Misspecification on Model Based Personalised Dosing. | 2016 Sep |
1 |
| 10 |
25515945 | Effects of CYP3A4 polymorphisms on the plasma concentration of voriconazole. | 2015 Apr |
3 |
| 11 |
24757038 | Iatrogenic cushing syndrome secondary to a probable interaction between voriconazole and budesonide. | 2014 Jul |
1 |
| 12 |
25429674 | Drug interactions between nine antifungal agents and drugs metabolized by human cytochromes P450. | 2014 |
1 |
| 13 |
23545593 | A case-report of unpredictable and massive voriconazole intoxication in a patient with extensive CYP2C19 and CYP2C9 polymorphisms. | 2013 |
3 |
| 14 |
20393255 | Interaction between voriconazole and glimepiride. | 2010 Jan-Mar |
1 |
| 15 |
20642349 | Pharmacokinetic variability of voriconazole and N-oxide voriconazole measured as therapeutic drug monitoring. | 2010 Oct |
2 |
| 16 |
19029318 | Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3A. | 2009 Feb |
4 |
| 17 |
19033450 | CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole. | 2009 Feb |
1 |
| 18 |
22478935 | Role of therapeutic drug monitoring of voriconazole in the treatment of invasive fungal infections. | 2009 Nov |
1 |
| 19 |
18025525 | Pharmacokinetic interaction between voriconazole and efavirenz at steady state in healthy male subjects. | 2008 Jan |
1 |
| 20 |
18362161 | Role of flavin-containing monooxygenase in oxidative metabolism of voriconazole by human liver microsomes. | 2008 Jun |
1 |
| 21 |
17646413 | Steady-state pharmacokinetic and safety profiles of voriconazole and ritonavir in healthy male subjects. | 2007 Oct |
1 |
| 22 |
16556082 | Drug interactions during therapy with three major groups of antimicrobial agents. | 2006 Apr |
1 |
| 23 |
16940139 | Safety of voriconazole in a patient with CYP2C9*2/CYP2C9*2 genotype. | 2006 Sep |
2 |
| 24 |
15914520 | Breakthrough Candida infections in patients receiving voriconazole. | 2005 Jul-Aug |
1 |
| 25 |
16141567 | Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes. | 2005 Sep |
1 |
| 26 |
16192747 | Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients. | 2005 Dec |
1 |
| 27 |
16205037 | [Drug-drug interaction of antifungal drugs]. | 2005 Oct |
2 |
| 28 |
12639175 | Voriconazole: a new triazole antifungal agent. | 2003 Mar |
1 |
| 29 |
12695341 | Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole. | 2003 May |
2 |
| 30 |
12867215 | Voriconazole. | 2003 May |
1 |
| 31 |
14616412 | Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration. | 2003 Dec |
1 |
| 32 |
14616414 | Histamine H2-receptor antagonists have no clinically significant effect on the steady-state pharmacokinetics of voriconazole. | 2003 Dec |
1 |
| 33 |
14616415 | Effect of omeprazole on the steady-state pharmacokinetics of voriconazole. | 2003 Dec |
1 |
| 34 |
14616416 | No clinically significant pharmacokinetic interactions between voriconazole and indinavir in healthy volunteers. | 2003 Dec |
1 |